Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with adjusted EPS of $2.77 and net earnings of $5.5 billion. Management raised ...

Afternoon storms could significantly impact air travel across the Midwest and Northeast including the cities of Chicago and ...

Andrea Gibson, featured in award-winning documentary, dies at 49 after cancer battle Trump set to sign executive order on ...

PotlatchDeltic (NASDAQ:PCH) +2.2% in Wednesday's trading as Truist upgraded the lumber real estate investment trust to Buy ...

Outlook: Have They Become Underrated?

U.S. economic activity increased slightly in recent weeks, but the outlook was neutral to slightly pessimistic, the Federal ...

Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter.

ASML Holding NV Chief Executive Officer Christophe Fouquet walked back his forecast that sales will grow next year, blaming ...

The Brazil Treasury's outlook for the country's gross public debt has worsened, with a forecast rise by 10.6 percentage points during President Luiz Inacio Lula da Silva's current term, 0.6 point ...

Johnson & Johnson’s stock rose 2.4% in premarket trading, enough to pace the Dow Jones Industrial Average’s early gainers.

Consumers are growing increasingly concerned about the inflationary impact of tariffs and plan to cut back on spending and the use of credit cards, according to a survey of 1,000 consumers by BTIG.